Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 10/20 | 0.57 |
| ▸ | CTSS | P25774 | 5/20 | 0.57 |
| ▸ | CTSL | P07711 | 2/20 | 0.56 |
| ▸ | CTSB | P07858 | 1/20 | 0.56 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.53 |
| ▸ | REN | P00797 | 2/20 | 0.44 |
| ▸ | MMP3 | P08254 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.42 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25869316 | 0.99 | CTSK (0.58) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL3826173 | 0.88 | CTSK (0.55) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL2118971 | 0.86 | CTSK (0.74) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL10605035 | 0.86 | CTSK (0.74) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL10944684 | 0.86 | CTSS (0.72) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL996962 | 0.86 | CTSS (0.72) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL24049265 | 0.84 | CTSS (0.50) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL20542828 | 0.81 | CAPN1 (0.72) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL20543147 | 0.81 | CAPN1 (0.72) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL20542827 | 0.81 | CAPN1 (0.72) | CTSKCTSSCTSLCTSBCAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234986-A1 | INHIBITORS OF CORONAVIRUS PROTEASE | SUNSHINE BIOPHARMA INC. | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234986-A1 | INHIBITORS OF CORONAVIRUS PROTEASE | ACE2, ACE, TMPRSS2 | CTSK 67/4885CTSS 27/4885CTSL 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.